import MCQGroup from '@/components/MCQGroup'
import { Callout } from 'nextra/components'

# Understanding Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia (ITP), formerly known as Immune Thrombocytopenic Purpura or Idiopathic Thrombocytopenic Purpura, is an autoimmune hematological disorder characterized by low platelet counts. This document provides an in-depth look at ITP, detailing its subtypes, clinical presentation, diagnosis, and management.

## Overview of ITP

ITP is divided into two main subtypes:

- **Primary ITP**: Defined as isolated thrombocytopenia (`<100x10⁹/L`) without an identifiable cause.
- **Secondary ITP**: Occurs with thrombocytopenia in the presence of an identifiable condition or medication.

ITP typically affects:

- Boys and girls younger than 10 years
- Men and women over 65 years
- Women of childbearing age

The clinical presentation of ITP varies widely, from asymptomatic cases discovered during routine testing to life-threatening hemorrhages.

## Diagnosis

ITP is considered a diagnosis of exclusion, necessitating a comprehensive history and examination. It is confirmed through laboratory findings of isolated thrombocytopenia (`<100x10⁹/L`).

**Typical signs and symptoms include:**

- Petechiae
- Bruising
- Unexplained or easy bleeding
- Potential fatigue related to ITP

**Risk factors encompass:**

- Secondary ITP-associated diseases
- Lymphoproliferative disorders
- HIV and Hepatitis C infections
- Autoimmune conditions, e.g., Systemic Lupus Erythematosus

Other notable risk factors are age-related (`<10 years` and `>65 years`), being a female of childbearing age, and having experienced recent viral illnesses.

## Investigations

Key investigations include:

- **Full Blood Count (FBC)**: Identifies isolated thrombocytopenia.
- **Peripheral Blood Smear**: Distinguishes thrombocytopenia from pseudothrombocytopenia, especially when blood is drawn using EDTA tubes.

Further testing to exclude causes of secondary ITP includes screening for HIV, Hepatitis C, and possibly performing a bone marrow biopsy. Testing thyroid function (TFTs) is recommended as ITP is linked with hyperthyroidism in 8–14% of cases.

## Management (Prescribing)

**Conservative management** is advised for asymptomatic cases or minor bleeding:

- **For children**: Observation without intervention is often sufficient.
- **For adults**: Treatment decisions hinge on bleeding severity and platelet count. 
  - Severe bleeding or platelet count `<30x10⁹/L` warrants corticosteroids with or without IVIG.
  - Platelet count `>30x10⁹/L` without severe bleeding suggests observation.

## Management (Non-prescribing)

Management strategies are influenced by the disease severity and laboratory results. Approximately 80% of children may achieve spontaneous remission. However, older patients and those unresponsive to treatment may face higher mortality risks. Observation is recommended for minor bleeding or asymptomatic cases, with a specialist consultation advised for chronic ITP cases.

<Callout emoji="⚠️">
**Warning:** Always assess the patient's bleeding risk and consult specialists for chronic cases or when standard treatments are ineffective.
</Callout>

## References

1. BMJ Best Practice: Scully M. Immune Thrombocytopenia. BMJ Best Practice. March 2019. [Link to source](https://bestpractice.bmj.com/topics/en-gb/138).
2. Bussel JB. Immune thrombocytopenia (ITP) in children: Clinical features and diagnosis. April 2020. UpToDate. [Link to source](https://www.uptodate.com/contents/immune-thrombocytopenia-itp-in-children-clinical-features-and-diagnosis).

---

<MCQGroup questions={[
  {
    question: "A 5-year-old boy presents with petechiae and bruising. He appears otherwise healthy, and his blood tests reveal isolated thrombocytopenia with a platelet count of 50x10⁹/L. He recently had a mild viral illness. Based on the typical management of Immune Thrombocytopenia (ITP) in children, what is the most appropriate next step in management?",
    options: [
      "Initiate corticosteroid therapy",
      "Administer Intravenous Immunoglobulin (IVIG)",
      "Observe without intervention",
      "Perform a bone marrow biopsy",
      "Start platelet transfusion"
    ],
    correctAnswer: 2,
    correctFeedback: "Correct! In children with ITP, especially those who have mild symptoms and no severe bleeding, observation without intervention is often sufficient as spontaneous remission is common.",
    incorrectFeedback: "Consider the mild nature of the symptoms and the high likelihood of spontaneous remission in children with ITP."
  },
  {
    question: "A 72-year-old woman presents with mucosal bleeding and a platelet count of 20x10⁹/L. She has a history of Systemic Lupus Erythematosus (SLE). Which condition is most likely responsible for her thrombocytopenia?",
    options: [
      "Primary ITP",
      "Secondary ITP due to SLE",
      "Heparin-induced thrombocytopenia",
      "Thrombotic thrombocytopenic purpura (TTP)",
      "Aplastic anemia"
    ],
    correctAnswer: 1,
    correctFeedback: "Correct! Secondary ITP is the best explanation for thrombocytopenia in this patient as it is associated with autoimmune conditions like SLE.",
    incorrectFeedback: "Think about the role SLE plays as a risk factor for secondary forms of Immune Thrombocytopenia."
  },
  {
    question: "A 30-year-old woman presents with easy bruising and a platelet count of 95x10⁹/L without any other abnormalities on her full blood count. Her medical history is significant for hyperthyroidism. What additional blood test might be particularly informative to support a full diagnosis?",
    options: [
      "Liver function tests",
      "Thyroid function tests",
      "Coagulation profile",
      "Vitamin B12 levels",
      "Serum ferritin"
    ],
    correctAnswer: 1,
    correctFeedback: "Correct! Thyroid function tests are relevant as ITP has been associated with hyperthyroidism in a subset of patients.",
    incorrectFeedback: "Consider the known association between immune thrombocytopenia and endocrine disorders such as hyperthyroidism."
  },
  {
    question: "Which patient demographic is least commonly affected by Immune Thrombocytopenia (ITP)?",
    options: [
      "Boys younger than 10 years",
      "Girls younger than 10 years",
      "Women of childbearing age",
      "Men over 65 years",
      "Men of childbearing age"
    ],
    correctAnswer: 4,
    correctFeedback: "Correct! ITP commonly affects boys and girls younger than 10, women of childbearing age, and individuals over 65. Men of childbearing age are not mentioned as a common affected demographic.",
    incorrectFeedback: "Review the demographics mentioned in the article to determine the common age and gender groups affected by ITP."
  }
]} />